Replay available

MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call

MaxCyte, Inc. (NASDAQ: MXCT) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Wed, May 7, 2025 at 4:30 PMendedReplay
MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Unnamed Analyst

Analyst

Julie Simmons

Analyst, PanMir Librem

Matt LaRue

Analyst, William Blair

Dan Arias

Analyst, Stifel

Chad Bytrowski

Analyst (on behalf of Brendan Smith)

Eric Abdaal

Investor Relations

Doug Swirsky

Chief Financial Officer

Mark Macero

Analyst, BTIG

Meher Masood

President and Chief Executive Officer

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the MaxSight first quarter earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, please press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Eric Abdaal, Investor Relations. Please go ahead. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MacSite, we have Meher Masood, President and Chief Executive Officer, and Doug Swirsky, Chief Financial Officer. Earlier today, MaxSight released financial results for the first quarter ended March 31st, 2025. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal security laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors, which are discussed in detail in our SEC filings. Except as required by applicable law, the company has no obligation to publicly update any forward-looking statements, whether because of new information, future events, or otherwise. And with that, I will turn the call over to Mehar. Thank you, Eric. Good afternoon, everyone, an...

More from Maxcyte, Inc.